Received: 28 February 2023 Accepted: 31 March 2023 DOI: 10.1111/jcpe.13823
CLINICAL PRACTICE GUIDELINE
Prevention and treatment of peri-implant diseases — TheEFP S3 level clinical practice guideline
David Herrera 1 Søren Jepsen 6
| Tord Berglundh 2 | Anton Sculean 7
| Frank Schwarz 3
| Iain Chapple 4,5
|
| Moritz Kebschull 4,5,8
|
Panos N. Papapanou 8
| Maurizio S. Tonetti 9
| Mariano Sanz 1
| on behalf of the
EFP workshop participants and methodological consultant 1 ETEP (Etiology and Therapy of Periodontal and Peri-implant Diseases) Research Group, University Complutense of Madrid, Madrid, Spain 2 Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 3 Department of Oral Surgery and Implantology, Johann Wolfgang Goethe-University, Frankfurt, Germany 4 Periodontal Research Group, Institute of Clinical Sciences, College of Medical & Dental Sciences, The University of Birmingham, Birmingham, UK 5 Birmingham Community Healthcare NHS Foundation Trust, Birmingham, UK 6 Department of Periodontology, Operative and Preventive Dentistry, University Hospital Bonn, Bonn, Germany 7 Department of Periodontology, School of Dental Medicine, University of Bern, Bern, Switzerland 8 Division of Periodontics, Section of Oral, Diagnostic and Rehabilitation Sciences, College of Dental Medicine, Columbia University, New York, New York, USA 9 Shanghai PerioImplant Innovation Center, Department of Oral and Maxillo-facial Implantology, Shanghai Key Laboratory of Stomatology, National Clinical Research Centre for Oral Diseases, Shanghai Ninth People Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Correspondence David Herrera, ETEP (Etiology and Therapy of Periodontal and Peri-implant Diseases) Research Group, Faculty of Odontology, University Complutense of Madrid, Plaza Ram on y Cajal s/n (Ciudad Universitaria), 28040 Madrid, Spain. Email: davidher@ucm.es
Abstract Background: The recently published Clinical Practice Guidelines (CPGs) for the treat- ment of stages I – IV periodontitis provided evidence-based recommendations for treating periodontitis patients, defined according to the 2018 classification. Peri- implant diseases were also re-defined in the 2018 classification. It is well established that both peri-implant mucositis and peri-implantitis are highly prevalent. In addition, peri-implantitis is particularly challenging to manage and is accompanied by signifi- cant morbidity. Aim: To develop an S3 level CPG for the prevention and treatment of peri-implant diseases, focusing on the implementation of interdisciplinary approaches required to prevent the development of peri-implant diseases or their recurrence, and to treat/ rehabilitate patients with dental implants following the development of peri-implant diseases. Materials and Methods: This S3 level CPG was developed by the European Federa- tion of Periodontology, following methodological guidance from the Association of Scientific Medical Societies in Germany and the Grading of Recommendations
Funding information European Federation of Periodontology
EFP workshop participants and methodological consultant are listed in Appendix.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2023 The Authors. Journal of Clinical Periodontology published by John Wiley & Sons Ltd.
4
J Clin Periodontol. 2023;50(Suppl. 26):4 – 76.
wileyonlinelibrary.com/journal/jcpe
Made with FlippingBook Annual report